Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data: A Comparison of Alternative Econometric Cost Modeling Techniques
暂无分享,去创建一个
M Christopher Roebuck | M. Roebuck | Christopher A Powers | Christina M Meyer | Baze Vaziri | B. Vaziri | C. Powers | C. Meyer | Christopher A. Powers | Christina M. Meyer | M Christopher Roebuck
[1] Michael J. Goodman,et al. Chronic Disease Score as a Predictor of Hospitalization , 2002, Epidemiology.
[2] M C Hornbrook,et al. Modeling risk using generalized linear models. , 1999, Journal of health economics.
[3] E H Wagner,et al. A chronic disease score from automated pharmacy data. , 1992, Journal of clinical epidemiology.
[4] J. Mullahy. Much Ado About Two: Reconsidering Retransformation and the Two-Part Model in Health Economics , 1998, Journal of health economics.
[5] A. Albert,et al. On the existence of maximum likelihood estimates in logistic regression models , 1984 .
[6] Paul Grootendorst,et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. , 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.
[7] G. Nichols,et al. Replicating the chronic disease score (CDS) from automated pharmacy data. , 1994, Journal of clinical epidemiology.
[8] S. Weisberg,et al. Diagnostics for heteroscedasticity in regression , 1983 .
[9] W. Manning,et al. Estimating Log Models: To Transform or Not to Transform? , 1999, Journal of health economics.
[10] T G Ganiats,et al. The Medicaid Rx Model: Pharmacy-Based Risk Adjustment for Public Programs , 2001, Medical care.
[11] N. Duan. Smearing Estimate: A Nonparametric Retransformation Method , 1983 .
[12] T. Breurch,et al. A simple test for heteroscedasticity and random coefficient variation (econometrica vol 47 , 1979 .
[13] Improving Risk Adjustment for Medicare Capitated Reimbursement Using Nonlinear Models , 2003, Medical care.
[14] D. Malone,et al. Development of a chronic disease indicator score using a Veterans Affairs Medical Center medication database. IMPROVE Investigators. , 1999, Journal of clinical epidemiology.
[15] Anne E Sales,et al. Predicting Costs of Care Using a Pharmacy-Based Measure Risk Adjustment in a Veteran Population , 2003, Medical care.
[16] L. Lamers. Pharmacy costs groups: a risk-adjuster for capitation payments based on the use of prescribed drugs. , 1999, Medical care.
[17] Melinda Beeuwkes Buntin,et al. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. , 2004, Journal of health economics.
[18] W. Manning,et al. The logged dependent variable, heteroscedasticity, and the retransformation problem. , 1998, Journal of health economics.
[19] R. Park. Estimation with Heteroscedastic Error Terms , 1966 .
[20] D. Price,et al. Database studies in asthma pharmacoeconomics: uses, limitations and quality markers , 2003, Expert opinion on pharmacotherapy.
[21] Anne E Sales,et al. Construction and Characteristics of the RxRisk-V: A VA-Adapted Pharmacy-Based Case-mix Instrument , 2003, Medical care.
[22] Gregory E. Simon,et al. A Chronic Disease Score with Empirically Derived Weights , 1995, Medical care.
[23] P. Fishman,et al. Development and estimation of a pediatric chronic disease score using automated pharmacy data. , 1999, Medical care.
[24] J Z Ayanian,et al. Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. , 2001, Health services research.
[25] Paul A. Fishman,et al. Risk Adjustment Using Automated Ambulatory Pharmacy Data: The RxRisk Model , 2003, Medical care.